These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 36974812)
21. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer. Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010 [TBL] [Abstract][Full Text] [Related]
22. The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis. Meng X; Chen M; Su W; Tao X; Sun M; Zou X; Ying R; Wei W; Wang B Stem Cell Res Ther; 2018 Apr; 9(1):85. PubMed ID: 29615103 [TBL] [Abstract][Full Text] [Related]
23. Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression. Kitagawa K; Shigemura K; Sung SY; Chen KC; Huang CC; Chiang YT; Liu MC; Huang TW; Yamamichi F; Shirakawa T; Fujisawa M J Cancer Res Clin Oncol; 2019 Sep; 145(9):2261-2271. PubMed ID: 31367836 [TBL] [Abstract][Full Text] [Related]
24. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801 [TBL] [Abstract][Full Text] [Related]
25. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway. Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010 [TBL] [Abstract][Full Text] [Related]
26. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway. Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437 [TBL] [Abstract][Full Text] [Related]
27. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
28. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition. Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848 [TBL] [Abstract][Full Text] [Related]
29. TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells. Ping Q; Wang C; Cheng X; Zhong Y; Yan R; Yang M; Shi Y; Li X; Li X; Huang W; Wang L; Bi X; Hu L; Yang Y; Wang Y; Gong R; Tan J; Li R; Li H; Li J; Wang W; Li R J Transl Med; 2023 Jul; 21(1):475. PubMed ID: 37461061 [TBL] [Abstract][Full Text] [Related]
30. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. McConkey DJ; Choi W; Marquis L; Martin F; Williams MB; Shah J; Svatek R; Das A; Adam L; Kamat A; Siefker-Radtke A; Dinney C Cancer Metastasis Rev; 2009 Dec; 28(3-4):335-44. PubMed ID: 20012924 [TBL] [Abstract][Full Text] [Related]
31. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder. Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277 [TBL] [Abstract][Full Text] [Related]
32. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway. Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254 [TBL] [Abstract][Full Text] [Related]
33. 1-Methyl-D-tryptophan potentiates TGF-β-induced epithelial-mesenchymal transition in T24 human bladder cancer cells. Brito RB; Malta CS; Souza DM; Matheus LH; Matos YS; Silva CS; Ferreira JM; Nunes VS; França CM; Dellê H PLoS One; 2015; 10(8):e0134858. PubMed ID: 26267811 [TBL] [Abstract][Full Text] [Related]
34. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. Lin L; Zhong K; Sun Z; Wu G; Ding G J Cancer Res Clin Oncol; 2012 Jan; 138(1):11-22. PubMed ID: 21947243 [TBL] [Abstract][Full Text] [Related]
35. Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition. Ding X; Wang Y; Ma X; Guo H; Yan X; Chi Q; Li J; Hou Y; Wang C Cell Prolif; 2014 Apr; 47(2):146-51. PubMed ID: 24571540 [TBL] [Abstract][Full Text] [Related]
36. Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. Shan Y; Zhang L; Bao Y; Li B; He C; Gao M; Feng X; Xu W; Zhang X; Wang S J Nutr Biochem; 2013 Jun; 24(6):1062-9. PubMed ID: 23159064 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of Snail in retinal pigment epithelial triggered epithelial-mesenchymal transition. Li H; Li M; Xu D; Zhao C; Liu G; Wang F Biochem Biophys Res Commun; 2014 Mar; 446(1):347-51. PubMed ID: 24607896 [TBL] [Abstract][Full Text] [Related]
38. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway. Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase. Li Y; Yang K; Mao Q; Zheng X; Kong D; Xie L Int Urol Nephrol; 2010 Jun; 42(2):315-23. PubMed ID: 19669587 [TBL] [Abstract][Full Text] [Related]
40. [SLC12A8 promotes proliferation, invasiveness, migration and epithelial-mesenchymal transition of bladder cancer cells by activating JAK/STAT singaling]. Zhang X; Wu H; Wang S Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1613-1621. PubMed ID: 37814877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]